E08.33 Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy

Name of the Condition

• Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy

Summary

This condition refers to diabetes mellitus that develops secondary to another underlying health issue, accompanied by moderate nonproliferative diabetic retinopathy. It involves damage to the retina due to prolonged high blood sugar levels, with changes that include more extensive microaneurysms, dot-blot hemorrhages, and hard exudates compared to mild nonproliferative retinopathy. The retinopathy is classified as moderate, indicating a progression from early-stage changes but without the abnormal blood vessel growth seen in proliferative retinopathy.

Causes

Diabetes mellitus due to an underlying condition occurs when another health issue impairs insulin production or function, leading to elevated blood glucose levels. These underlying conditions may include pancreatic disease, hormonal disorders, or certain genetic syndromes. The resulting hyperglycemia damages blood vessels and tissues in the retina over time, causing nonproliferative changes. Moderate nonproliferative diabetic retinopathy represents a stage where retinal damage is more pronounced than in mild cases but has not yet progressed to proliferative changes.

Risk Factors

• Having an underlying condition that affects insulin or glucose metabolism.
• Long-standing uncontrolled diabetes.
• High blood pressure and high cholesterol.
• Smoking and obesity.
• Advanced age.

Symptoms

• Blurred or distorted vision.
• Floaters or dark spots in the field of vision.
• Difficulty seeing colors.
• Poor night vision.
• Vision loss, which may be gradual or sudden.

Diagnosis

Diagnosis involves a comprehensive eye examination, including a dilated retinal exam and imaging studies such as optical coherence tomography (OCT) or fundus photography. Blood tests to assess glycemic control and identify underlying conditions contributing to diabetes may also be performed. The classification of retinopathy as moderate nonproliferative is based on the extent of retinal findings, such as the number and distribution of microaneurysms, hemorrhages, and exudates.

Treatment Options

Management focuses on controlling blood glucose levels through lifestyle modifications, medications, or insulin therapy. Blood pressure and cholesterol management are also critical. For retinopathy, treatment may include laser therapy or anti-VEGF injections if macular edema or vision-threatening changes develop. Regular monitoring by an ophthalmologist is essential to track progression and adjust interventions.

Prognosis and Follow-Up

With proper glycemic control and regular eye care, the progression of moderate nonproliferative diabetic retinopathy can be slowed. However, without intervention, it may advance to severe nonproliferative or proliferative retinopathy, increasing the risk of vision loss. Follow-up typically involves periodic eye examinations, with frequency determined by the severity of retinopathy and response to treatment.

Complications

• Progression to severe nonproliferative or proliferative diabetic retinopathy.
• Macular edema, leading to central vision loss.
• Retinal detachment.
• Vision impairment or blindness if left untreated.

Lifestyle & Prevention

• Maintain tight glycemic control through diet, exercise, and medication adherence.
• Manage blood pressure and cholesterol levels.
• Avoid smoking and limit alcohol intake.
• Regular eye examinations to detect retinopathy early.
• Protect eyes from UV light and injury.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden vision changes, increased floaters, or eye pain. Regular follow-up with both an endocrinologist and ophthalmologist is recommended to monitor diabetes and retinopathy progression.

Tips for Medical Coders

Document the underlying condition causing diabetes and the specific retinopathy stage (moderate nonproliferative) to support accurate coding. Ensure clinical notes reflect the extent of retinal findings and any interventions performed. Code E08.33 is specific to moderate nonproliferative diabetic retinopathy; use additional codes for underlying conditions or comorbidities as applicable.